• Mutation; HGNC; 11998; TP53; Simple; p.Ser241Phe (c.722C>T); ClinVar=VCV000012359; Zygosity=Unspecified (PubMed=7651727).
  

PubMed=3442732; DOI=10.3109/07357908709020314
Niles R.M., Wilhelm S.A., Steele G.D. Jr., Burke B., Christensen T., Dexter D.L., O'Brien M.J., Thomas P., Zamcheck N.
Isolation and characterization of an undifferentiated human colon carcinoma cell line (MIP-101).
Cancer Invest. 5:545-552(1987)

PubMed=2228514
Wagner H.E., Thomas P., Wolf B.C., Zamcheck N., Jessup J.M., Steele G.D. Jr.
Characterization of the tumorigenic and metastatic potential of a poorly differentiated human colon cancer cell line.
Invasion Metastasis 10:253-266(1990)

PubMed=7651727
Kastrinakis W.V., Ramchurren N., Rieger K.M., Hess D.T., Loda M., Steele G., Summerhayes I.C.
Increased incidence of p53 mutations is associated with hepatic metastasis in colorectal neoplastic progression.
Oncogene 11:647-652(1995)

PubMed=7757961; DOI=10.1016/0304-3835(95)03764-n
Thomas P., Gangopadhyay A., Steele G.D. Jr., Andrews C., Nakazato H., Oikawa S., Jessup J.M.
The effect of transfection of the CEA gene on the metastatic behavior of the human colorectal cancer cell line MIP-101.
Cancer Lett. 92:59-66(1995)

PubMed=10949995; DOI=10.1290/1071-2690(2000)036<0367:MCRAAI>2.0.CO;2
Jessup J.M., Frantz M., Sonmez-Alpan E., Locker J.D., Skena K., Waller H., Battle P., Nachman A., Weber M.E., Thomas D.A., Curbeam R.L. Jr., Baker T.L., Goodwin T.J.
Microgravity culture reduces apoptosis and increases the differentiation of a human colorectal carcinoma cell line.
In Vitro Cell. Dev. Biol. Anim. 36:367-373(2000)

PubMed=15902309; DOI=10.1172/JCI23002
Tai I.T., Dai M., Owen D.A., Chen L.B.
Genome-wide expression analysis of therapy-resistant tumors reveals SPARC as a novel target for cancer therapy.
J. Clin. Invest. 115:1492-1502(2005)

PubMed=20835245; DOI=10.1038/nmeth.1503
Griffith M., Griffith O.L., Mwenifumbo J., Goya R., Morrissy A.S., Morin R.D., Corbett R., Tang M.J., Hou Y.-C., Pugh T.J., Robertson G., Chittaranjan S., Ally A., Asano J.K., Chan S.Y., Li H.-Y.I., McDonald H., Teague K., Zhao Y.-J., Zeng T., Delaney A., Hirst M., Morin G.B., Jones S.J.M., Tai I.T., Marra M.A.
Alternative expression analysis by RNA sequencing.
Nat. Methods 7:843-847(2010)

PubMed=23671654; DOI=10.1371/journal.pone.0063056
Lu Y.-H., Soong T.D., Elemento O.
A novel approach for characterizing microsatellite instability in cancer cells.
PLoS ONE 8:E63056-E63056(2013)

PubMed=25960936; DOI=10.4161/21624011.2014.954893
Boegel S., Lower M., Bukur T., Sahin U., Castle J.C.
A catalog of HLA type, HLA expression, and neo-epitope candidates in human cancer cell lines.
OncoImmunology 3:e954893.1-e954893.12(2014)

PubMed=25926053; DOI=10.1038/ncomms8002
Medico E., Russo M., Picco G., Cancelliere C., Valtorta E., Corti G., Buscarino M., Isella C., Lamba S., Martinoglio B., Veronese S., Siena S., Sartore-Bianchi A., Beccuti M., Mottolese M., Linnebacher M., Cordero F., Di Nicolantonio F., Bardelli A.
The molecular landscape of colorectal cancer cell lines unveils clinically actionable kinase targets.
Nat. Commun. 6:7002.1-7002.10(2015)